CV Lattes
ResearcherID
ORCID
Universidade de São Paulo (USP). Instituto de Psicologia (IP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Associate Professor (Institute of Biomedical Sciences) at the University of Sao Paulo.She holds a master's degree and a doctorate from the Institute of Biomedical Sciences-ICB of the University of Sao Paulo; Post-doctorate from the University of Heidelberg- Germany; works in collaboration with the Faculty of Medicine of USP (Department of Surgery-Anesthesiology) and Butantan Institute, in addition to collaboration with the laboratory of Dr. Linda Watkins from the University of Colorado at Boulder, where she did part of her PhD and her sabbatical as a visiting professor (2022). She has experience in the field of neuroanatomy, pharmacology, with emphasis on Pain and Neuroscience, working mainly on the following topics: neuropathic pain and muscle pain, nociception, as well as different mediators of the inflammatory response. Also, it has an experimental line of non-pharmacological treatment to improve various types of pain, through the use of models such as exercise and photobiomodulation. She is currently vice-coordinator of Animal Care from Department of Anatomy-ICB-USP, member of the ethics committee in the use of animals (CEUA) of the ICB-USP. Advisor in the Postgraduate Programs at the Department of Anatomy of the Institute of Biomedical Sciences - ICB/USP. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Neuropathic pain affects approximately 16 million people and, despite its great social and personal impact, currently available treatments are inadequate and have limiting side effects, including the risk of abuse. There is an urgent need to find new, effective, and safe approaches to treating neuropathic pain, as well as understanding the biological effects underlying non-pharmacological…
In clinical practice it has been extensively reported that neuropathic pain is difficult to treat due to inadequate understanding of the cellular and molecular mechanisms involved in the development and maintenance of this type of pain. Therapeutic options for pain control have increased in recent years. However, the responses to conventional treatments (such as pills ) are not satisfacto…
The technique of photobiostimulation, use of light as therapy, is a non-invasive method that has been shown both in basic and in clinical research to be effective in reducing pain sensitivity and consequently improving the quality of life of patients with neuropathic pain. The present study aims to examine the effects of low level laser (LLLT) on pain sensitivity and sciatic nerve repair …
Trigeminal neuralgia (NT) is a common cause of facial pain. It has a significant impact on quality of life and socioeconomic functioning of the patient. The International Association for the Study of Pain (IASP) defines NT as a painful unilateral disorder characterized by episodes of pain like an electric shock that begin and end by abrupt way. Among several models of neuropathy using ner…
(Only some records are available in English at this moment)
Fibromyalgia is a chronic pain syndrome that manifests in various ways, including symptoms such as musculoskeletal pain, fatigue, sleep disturbances, anxiety, depression, and cognitive issues, significantly impacting the quality of life of those affected. The etiology of fibromyalgia is multifactorial, and there is no definitive cure. Therefore, its treatment requires comprehensive, multi…
Neuropathic pain is a difficult-to-treat chronic pain that affects a significant portion, reaching up to 10% of the population, and has a substantial impact on quality of life. It is therefore considered a public health problem. In recent years, new therapeutic approaches for the management of neuropathic pain, such as photobiomodulation, have emerged, although they are not effective for …
About 425 million people around the world are Diabetic, and approximately 60 % develop Peripheral Diabetic Neuropathy (PDN), which is characterized by moderate to severe pain involving the upper and lower limbs. The painful symptoms appear after metabolic alterations in the Dorsal Root Ganglia (DRG) afferent neurons and in the Schwann cells from the peripheral nerves, causing it progressi…
Parkinson's disease (PD) is the second most common neurodegenerative disease among elderly people, causing a large socioeconomic impact with increasing life expectancy of worldwide. In addition to motor symptoms, there is a high prevalence of pain symptoms which can be responsible for worsening patient's quality of life. Physical exercise, in turn, has already been described for its benef…
(Only some records are available in English at this moment)
Major depressive disorder (MDD) is a severe disorder affecting 21 million Americans (~10 %) per year and is the third leading cause of global disability. There is evidence that the prevalence of MDD is moderately increased in prediabetic patients and in undiagnosed diabetic patients, and markedly increased in the previously diagnosed diabetic patients compared to normal glucose metabolism…
Chronic pain disorders are a public health problem due to its high prevalence, high economic cost, and negative impact on patient quality of life. Animal models of chronic inflammatory and neuropathic pain represent an unprecedented opportunity to identify novel mechanisms underlying both their production and their effective management. Recent development of genetic tools for high spatial…
For a long time, much attention has been given to the detrimental effects of diabetes in the peripheral nervous system. Chronic hyperglycemia has also deleterious effects in the central nervous system (CNS) in the long term and when left untreated. Microglia, the resident macrophages in the CNS play a key role in maintaining homeostasis and in driving a variety of CNS diseases, including …
(Only some records are available in English at this moment)
| 2 / 2 | Ongoing grants |
| 5 / 4 | Completed research grants |
| 3 / 3 | Ongoing scholarships in Brazil |
| 31 / 23 | Completed scholarships in Brazil |
| 10 / 9 | Completed scholarships abroad |
| 51 / 41 | All research grants and scholarships |
| Associated processes | |